-Achieves the territory goals through effective planning, sales execution and fully leveraging Luminex business model.-Leads and executes regional strategies and tactics, and collaborates with global product marketing, regional marketing, partner management, and other functional teams for the purposes of exceeding customer expectations and increasing the adoption of Luminex products and solutions.-Executes a number of key initiatives associated with Luminex products that are intended for use in life science research laboratories.-Execute and manages opportunities requiring the direct acquisition of products from Luminex.-Develop strategies of Luminex's existing partner relationships in Life Science Research & Diagnostics.-Acts as Luminex relationship liaison and manage the Company's existing relationships with Luminex's Partners in the field to drive instrument placements and end user kit sales.-Develop strategic revenue plans with Luminex Partners to drive commercial execution and customer satisfaction.-Ownership of managing and developing strategic relationships within assigned Luminex's partners and customers to foster long-term alliances capable of addressing ambiguities and dynamic business challenges.-Problem solve and willingness to think creatively to achieve research solutions.

The Steve Nash Foundation focuses its resources on underserved populations of children at home in British Columbia and around the world. By supporting existing organizations with funding and technical assistance, and by thoughtfully addressing global and local challenges by innovating in and collaborating on critical areas of inquiry, we work to implement strategies that empower communities. Areas of focus include early childhood development and health, and neuroscience around child abuse and neglect, with a goal of improved outcomes for children of all socio-economic backgrounds. When we give kids attention, we give our communities hope.

Sales/Technical Specialist for biomarker Immunoassays including Milliplex/Luminex technology, ELISAs, and SMC (Singulex) technology. Provide technical expertise and seminars, trouble-shooting help 24/7 and sales to bridge research gaps for researchers across all industries.

Sales/Technical Specialist for biomarker Luminex/Milliplex technology, ELISAs, SMC (Singulex) technology, Guava EasyCyte flow cytometry, Muse Cell Analyzer, and Direct Detect protein quantification. Provide technical expertise and seminars, trouble-shooting help 24/7 and sales to bridge research gaps for researchers across all industries.

-Solely accountable for the achievement of all sales targets designed by EMD-Millipore Management for the Protein Analysis portfolio: Milliplex/ELISA/RIA kits, Luminex instrumentation and Direct Detect. -Provide technical seminars and effectively demonstrate Luminex instrumentation and Multiplex kits at research customer sites.-Recognize and understand the researcher's application, uncover pain points and make the appropriate solution recommendations.-Maximize active selling time and territory management by utilizing existing resources for after sale tasks such as: technical support, Luminex instrumentation/kit training, data analysis, quality complaints, trouble shooting, delivery issues and expediting.-Responsible for all quote generation and pricing inquiries where required. -Apply the Protein Analysis technologies in the customer’s workflow.

-Works with Account Managers to identify business opportunities, understand customer research needs, and position appropriate EMD-Millipore products and solutions.-Responsible for providing highly technical pre-sales and post-sales support to Account Managers and customers adopting, converting to, and/or optimizing/troubleshooting EMD-Millipore portfolio products.-Give customer presentations and seminars on key focus products within the EMD-Millipore portfolio-Responsible for manually demonstrating products and applications in key accounts and training customer and Account Managers on proper usage.-Plays a key role in enhancing differentiation of products and services on scientific, technical, and competitive principles.-Assists Marketing & R&D partners in assessing potential applications of company products to meet customer needs.-Provides feedback on market needs and issues with products and applications to Technical Services, R&D and Product Management.-Support sales in marketing new products and applications through technical seminars, poster sessions, demonstrations, focused sales calls, and thought-leader networking.-Network with opinion leaders in key focus product areas.-Supports EMD Millipore Bioscience products, focused specifically on the Muse and Direct Detect platform systems, stem cell and cell biology devices, medias, cell lines, growth factors and antibodies; Guava and Luminex platform based kits and instrumentation; Signaling/Epigenetic/Neuroscience antibodies and kits; Western blot membranes and detection reagents; and sterile filtration and sample prep devices.

My current research focuses on Shh signaling inactivating the tumor suppressor Retinoblastoma (Rb), inducing the Rb target E2F1 and gene regulator peroxisome proliferator-activated receptor γ (PPARγ) in cerebellar neural progenitor cells and in mouse medulloblastoma models. We find Shh-mediated Rb inactivation and E2F1/PPARγ induction promote cancer cell metabolism via glycolysis and mitochondrial fatty acid synthesis, generating a bioenergetic environment permissive for rapid proliferation in progenitor and tumor cells. We are currently investigating pharmacological targets to inhibit tumor growth through cell metabolism in medulloblastoma.

I have initiated several research projects aimed at evaluating the mTOR pathway, which is important for cell growth and protein translation, in an effort to identify potential targets for therapeutic intervention. These studies primarily involved on understanding the heterotypic crosstalk operating between Sonic hedgehog signaling and the mTOR pathway in the childhood brain tumor medulloblastoma, and have led to the identification of critical mediators specific for these tumor cells. Working with similar cellular systems, recent studies I conducted also led to dual roles of tumor suppressor p27Kip1 in medulloblastoma based on cellular localization: nuclear tumor suppressor and cytoplasmic oncogene.

My graduate Ph.D. thesis has led to numerous findings:1) 15-Lipoxygenase 2, an arachidonic acid (AA)-metabolizing enzyme, is involved in controlling cell proliferation in normal human prostate (NHP) progenitor cells and prostate cancer cells via AA-dependent and AA-independent metabolic pathways. 2) Immortalized human prostate epithelial cells via hTERT overexpression and inhibition of p16/Rb pathway leads to normal development of prostatic glands in tissue recombination through maintenance of stem/progenitor cell markers CD44, p63, alpha2beta1 integrin, and CK5.3) Fusion of human prostate epithelial (NHP) cells with tumor cells and inhibition of tumorigenicity in NHP-tumor cell hybrids by p16 and hTERT.